Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Neuroimaging study reveals structural changes in the brain of migraine patients

A neuroimaging study recently published in the journal Cephalalgia, the official journal of the International Headache Society, shared more evidence of structural changes in the brain of migraine patients.

13 Jan 2020

Beckman Coulter collaborates with SWLP to aid sepsis diagnosis and management in the UK

Beckman Coulter , a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 hematology analyzers and the Early Sepsis Indicator across the SWLP network.

From Beckman Coulter Diagnostics 9 Jan 2020

UC Riverside research team receives NIH grant to study breast cancer

A research team led by biochemists at the University of California, Riverside, has received a four-year grant from the National Institutes of Health, or NIH, to study breast cancer -- the most common cancer in women worldwide -- and the racial disparities in the treatment of the disease.

8 Jan 2020

Missing one night of sleep may increase Alzheimer's biomarker, study finds

A preliminary study has found that when young, healthy men were deprived of just one night of sleep, they had higher levels of tau, a biomarker for Alzheimer's disease, in their blood than when they had a full, uninterrupted night of rest.

8 Jan 2020

New antibody-drug conjugate shows promising activity in salivary gland tumors

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

7 Jan 2020

New clinical study to test retinal screening processes for early detection of Alzheimer's disease

The University of Rhode Island, in collaboration with BayCare Health System in Florida and The Memory and Aging Program at Butler Hospital, an affiliate of The Warren Alpert Medical School of Brown University, is launching a clinical trial of retinal screening processes that could help clinicians detect Alzheimer's disease possibly two or more decades before patients develop life-altering clinical symptoms.

6 Jan 2020

Researchers offer new perspective on pyrethroid insecticides

In an invited Commentary just published in JAMA Internal Medicine, Columbia Mailman School of Public Health professors Drs. Steven Stellman and Jeanne Mager Stellman offer their perspective on results from a recent study on Pyrethroid, among the most widely used insecticides in the world for public health control of vector-borne illnesses, including West Nile virus.

3 Jan 2020

Study reveals new way to predict risk of death for people with stable heart failure

A UCLA-led study revealed a new way to predict which patients with "stable" heart failure - those who have heart injury but do not require hospitalization - have a higher risk of dying within one to three years.

3 Jan 2020

Amyloid plaques may not necessarily come first in Alzheimer's disease, suggests new study

The scientific community has long believed that beta-amyloid, a protein that can clump together and form sticky plaques in the brain, is the first sign of Alzheimer's disease. Beta-amyloid then leads to other brain changes including neurodegeneration and eventually to thinking and memory problems. But a new study challenges that theory.

30 Dec 2019

Scientists discover potential drug compounds that target common type of liver cancer

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)'s Genome Institute of Singapore have discovered four potential drug compounds that target hepatocellular carcinoma, the most common type of liver cancer.

30 Dec 2019

Common cardiac blood test before surgery can predict post-operative complications

A common cardiac blood test done before surgery can predict who will experience adverse outcomes after most types of surgery, says an international study led by Hamilton researchers.

23 Dec 2019

Sphingotec's new biomarker bio-ADM identifies ICU patients who need immediate organ support

Diagnostics company SphingoTec GmbH today announced a publication in Critical Care1 with data on 2,000 ICU patients demonstrating that sphingotec's proprietary biomarker bio-ADM (Bioactive Adrenomedullin) not only identifies high-risk patients for septic shock at admission but also identifies patients in the general ICU patient population who require immediate life-saving therapeutic intervention.

23 Dec 2019

Sphingotec's penKid is a reliable marker for detection and monitoring of acute kidney injury

Diagnostics company SphingoTec GmbH today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC Emergency Medicine.

21 Dec 2019

Researchers locate brain biomarkers for detecting Alzheimer's disease

From the detection of functional brain changes that occur during Alzheimer's Disease, a research team from the Complutense University of Madrid has located a set of biomarkers that could predict which patients with Mild Cognitive Impairment have a higher risk of developing dementia.

20 Dec 2019

Data results of NCI-MATCH trial in tumors with DNA mismatch repair deficiencies

Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).

20 Dec 2019

$Powerful new tool developed to predict spinal fractures in patients$

Powerful new tool developed to predict spinal fractures in patients

Osteoporotic vertebral fractures are a prevalent skeletal condition in the elderly, which occurs due to a net loss in bone density with the inevitable onset of aging.

19 Dec 2019

A fast, sensitive technique to detect cancer markers brings liquid biopsy closer to clinic

A fast, inexpensive yet sensitive technique to detect cancer markers is bringing researchers closer to a "liquid biopsy" - a test using a small sample of blood or serum to detect cancer, rather than the invasive tissue sampling routinely used for diagnosis.

18 Dec 2019

Biomarker News and Research

Further Reading

Neuroimaging study reveals structural changes in the brain of migraine patients

Beckman Coulter collaborates with SWLP to aid sepsis diagnosis and management in the UK

UC Riverside research team receives NIH grant to study breast cancer

Missing one night of sleep may increase Alzheimer's biomarker, study finds

New antibody-drug conjugate shows promising activity in salivary gland tumors

New clinical study to test retinal screening processes for early detection of Alzheimer's disease

Researchers offer new perspective on pyrethroid insecticides

Study reveals new way to predict risk of death for people with stable heart failure

Amyloid plaques may not necessarily come first in Alzheimer's disease, suggests new study

Scientists discover potential drug compounds that target common type of liver cancer

Common cardiac blood test before surgery can predict post-operative complications

Sphingotec's new biomarker bio-ADM identifies ICU patients who need immediate organ support

Sphingotec's penKid is a reliable marker for detection and monitoring of acute kidney injury

Researchers locate brain biomarkers for detecting Alzheimer's disease

Data results of NCI-MATCH trial in tumors with DNA mismatch repair deficiencies

Powerful new tool developed to predict spinal fractures in patients

A fast, sensitive technique to detect cancer markers brings liquid biopsy closer to clinic

Scientists evaluate HIV/AIDS, diabetes and organ transplant drugs as possible therapies for Alzheimer's

Olympus and Ultivue Announce Comarketing Agreement for Leading-Edge Fluorescent Multiplexing Solution

New technique could lead to better diagnosis and effective tracking of Huntington’s disease

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo